Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

MHRA recalls myoma drug Esmya 5 mg tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a recall for 5mg ulipristal acetate (Esmya) tablets.

The regulator directed pharmacists to stop supplying the drug - used to treat uterine fibroids, commonly known as myomas - immediately and remove the products from the shelves. They should quarantine all remaining stock and return to the supplier.


The recall, applicable to patients, pharmacies and wholesalers, follows a new case of liver failure requiring liver transplant in a patient taking the medicine.

MHRA said it is reviewing the safety of the drug, and urged patients to stop taking the drug as soon as possible and contact their doctors for advice on alternative treatments.

“To protect patients, we are recommending that women stop taking Esmya for uterine fibroids, while the safety of this medicine is being reviewed,” said Dr Sarah Branch, Director of Vigilance and Risk Management of Medicines at the MHRA.

“If patients suffer nausea, vomiting, right hypochondrial pain, anorexia, asthenia or jaundice, even after they have stopped the treatment they should report these symptoms to a healthcare professional.

“We are asking healthcare professionals to help us ensure patient safety by not prescribing this medicine to new patients and contacting any patient currently taking Esmya to advise them to stop taking the medicine.”

The agency advised healthcare professionals and retailers to contact patients who have been supplied Esmya. They should ask them to stop taking their medication and return any unused medicine to their pharmacy.

Healthcare professionals should also alert patients to immediately report signs and symptoms of liver injury (such as nausea, vomiting, right hypochondrial pain, anorexia, asthenia, jaundice) which could occur after stopping treatment.

Liver function testing should be performed 2- 4 weeks after treatment has stopped as described in the product information for the medicines, it added.

Any suspicious side effects can be reported via the Yellow Card Scheme.

More For You

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Community Pharmacy England (CPE) chief executive Janet Morrison was one of the signatories of the statement

Primary care leaders join forces in effort to 'transform investment into primary care'

Community Pharmacy England (CPE) has teamed up with other national primary care bodies to urge the government to allocate more funds towards the sector.

In a joint statement released on the back of the government’s spending review, last week, the organisations welcomed the government’s continued determination to ‘shift care from hospitals to community and from sickness to prevention’ but warned that this would not be possible ‘without further investment in primary care’.

Keep ReadingShow less
Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less
Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology

The FLOWRx auto hub in the new Kamson warehouse in Uckfield.

Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology


Kamsons Pharmacy has announced that it has implemented a state-of-the-art hub and spoke dispensing model with the aim of freeing up more time to deliver clinical services.

Keep ReadingShow less
RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less
Older adult organizing medicine bottles in a cool, dry storage area during warm weather.

People are being advised to keep medicine below 25° C

Pic credit: iStock

Pharmacies advise patients on storing medicines safely during heatwave

Patients are being given important advice and guidance on the impact heat can have on their medicine and where to keep different medicines as the UK goes through a heatwave.

People are being advised to keep medicine below 25° C if they are able to, unless storage instructions state it needs to be kept at an alternative temperature, such as drugs that need to be refrigerated.

Keep ReadingShow less